Description

7-Benzyl-1-Bromo-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine is a high-purity, advanced pharmaceutical intermediate characterized by its unique fused heterocyclic structure. This compound is of significant commercial importance as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring complex molecular architectures. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the development of new drug candidates, especially within medicinal chemistry and process R&D.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of potential drug molecules targeting central nervous system (CNS) disorders, oncology, and other therapeutic areas.
• Medicinal Chemistry Research: Used as a versatile scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Process Chemistry Development: Employed in route scouting and scale-up studies for the efficient and cost-effective production of target APIs.
• Chemical Biology Probes: Can be utilized to create labeled or modified compounds for studying biological pathways and target engagement.
• Custom Synthesis: A starting material for contract research and manufacturing organizations (CROs/CMOs) producing bespoke compounds for client projects.

Basic Information

Product Name	7-Benzyl-1-Bromo-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine
CAS No.	1188264-70-1
Molecular Formula	C₁₃H₁₄BrN₃
Molecular Weight	292.18 g/mol
Synonyms	1-Bromo-7-benzyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine; 7-Benzyl-1-bromo-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine; Imidazo[1,5-a]pyrazine, 1-bromo-7-benzyl-5,6,7,8-tetrahydro-; 1188264-70-1; 1-Bromo-7-benzyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine; 7-Benzyl-1-bromo-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine; 1-Bromo-7-phenylmethyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine
EINECS	Contact for details

Quality Control

Our 7-Benzyl-1-Bromo-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine is produced under strict quality management systems to ensure batch-to-batch consistency and high purity, suitable for demanding research and development applications. All products undergo rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to confirm identity and purity. A comprehensive Certificate of Analysis (COA) detailing all test results is provided with each shipment and is available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed to prevent degradation from atmospheric moisture. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms
Identification (NMR)	Conforms
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.